Miriam Cha

Miriam Cha has extensive work experience in the biotechnology and pharmaceutical industry. Miriam first served as the Managing Director at MCEG Group from June 2010 to December 2018. Afterwards, they joined Rahko as the Chief Operating Officer and Co-Founder in June 2018, leading the company's quantum drug discovery efforts. Miriam recently transitioned to Odyssey Therapeutics as the Head of Operations (London) since January 2022 after Rahko was acquired by Odyssey.

Miriam Cha completed their Higher School Certificate at North Sydney Girls High School in 2002. Miriam then obtained a Bachelor of Laws degree from The Australian National University in 2006.